Johnson & Johnson and its U.S.-based subsidiary Janssen have reached a settlement agreement with the State of New Hampshire to resolve opioid allegations.  J&J will pay $39 million and an additional roughly $1.5 million to New Hampshire under the deal, which relates to a suit filed in 2018. New Hampshire will be reimbursed for the…